Rigel Pharmaceuticals (RIGL) Operating Income Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
43.16% |
| Date | Value |
|---|
| Mar 31, 2026 |
43.16% |
| Dec 31, 2025 |
123.37% |
| Sep 30, 2025 |
52.47% |
| Jun 30, 2025 |
88.64% |
| Mar 31, 2025 |
35.47% |
| Dec 31, 2024 |
40.57% |
| Sep 30, 2024 |
39.43% |
| Jun 30, 2024 |
26.71% |
| Mar 31, 2024 |
-29.40% |
| Dec 31, 2023 |
28.15% |
| Sep 30, 2023 |
31.32% |
| Jun 30, 2023 |
32.85% |
| Mar 31, 2023 |
-37.60% |
| Dec 31, 2022 |
28.46% |
| Sep 30, 2022 |
-15.20% |
| Jun 30, 2022 |
15.30% |
| Mar 31, 2022 |
-12.63% |
| Dec 31, 2021 |
-118.69% |
| Sep 30, 2021 |
6.71% |
| Jun 30, 2021 |
20.65% |
